Results 221 to 230 of about 602,440 (286)

Mapping Uncertain Risks and Impacts of Substances of Concern in Product Life Cycles - An SSbD Tool for Product Developers. [PDF]

Circ Econ Sustain
Bolaños Arriola J, Weber M, van Dulmen N, Guinée J, Vijver MG, Balkenende R.   +5 more
europepmc   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Assessing measurement bias in substance use disorder criteria associated with childhood adversity and genetic liability. [PDF]

Psychol Addict Behav
Davis CN, SooHoo J, Han A, Gelernter J, Feinn R, Kranzler HR.   +5 more
europepmc   +1 more source

Integrating Time‐Adjusted Imaging Instability Into Functional Outcome Prediction After Intracerebral Hemorrhage: Development and Validation of the HAGIV Score

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early risk stratification may support clinical decision‐making in spontaneous intracerebral hemorrhage (ICH). We aimed to develop and internally validate HAGIV, a score integrating frequency of imaging markers (FIM), a time‐adjusted non‐contrast computed tomography (CT) metric of hematoma expansion, with established predictors for 90‐
Lei Song, Ren Ke, Anqi Chen, Yufei Fu, Hang Zhou, Rujia Wang, Liwei Zou, Yongqiang Yu, Ming Yuan, Xiaoming Qiu, Mengzhou Xue   +10 more
wiley   +1 more source

Substance Use in Sports: A Cross-Sectional Study Among Professional Footballers in Accra, Ghana. [PDF]

Health Sci Rep
Odei I, Essuman YA, Ofori-Atta AL.
europepmc   +1 more source

Clinical and Modifiable Factors Associated With Disability and Relapse in MOGAD: A Multicentre Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang, Shaoxin Tao, Qiujia Wang, Xiaoyu Xu, Hui Yao, Zheng Liu, Dawei Li, Zhandong Qiu, Jinming Han, Jiangwei Xia, Qi Wang, Jun Sun, Kai Shao, Jiao Li, Shishuang Ruan, Yi Zhong, Jun Guo, Shougang Guo, Yue Huang, Guoliang Chai, Tao Jin, Hongyu Zhou, Junwei Hao, Yinan Zhao   +23 more
wiley   +1 more source

Discrimination, depressive symptoms, and prescription opioid misuse among adults with chronic pain who engage in hazardous drinking. [PDF]

Am J Drug Alcohol Abuse
Carlin VE, Lape EC, Deyo AG, Ripley GH, Polhill SE, Zale EL, Nam JK, Zvolensky MJ, Maisto SA, Ditre JW.   +9 more
europepmc   +1 more source

Having conversations about alcohol in frontline healthcare services: Experiences and perceptions of consumers and healthcare staff. [PDF]

PLOS Glob Public Health
Hayward B, Herbert S, Sharpe S, Silailai L, Pomare H, Eydt E, Tangaere K.   +6 more
europepmc   +1 more source

Prenatal Alcohol Exposure and the Development of Multiple Risk Behaviors in Adolescence: A Birth Cohort Study. [PDF]

Alcohol Clin Exp Res (Hoboken)
Parsonage JTI, Tinner L, Troy D, Taylor CM, McQuire C.   +4 more
europepmc   +1 more source

Infant Caregiving as a Resilience Factor for Postpartum Substance Misuse: A Scoping Review. [PDF]

Advers Resil Sci
Linde-Krieger LB, Chalke AM, Nelson M, Grisham LM, Rankin L, Bigelow AE, Xia X, Mallahan S, Tecot S, Allen AM.   +9 more
europepmc   +1 more source